Comparison of detection methods and follow-up study on the tyrosine kinase inhibitors therapy in non-small cell lung cancer patients with ROS1 fusion rearrangement

被引：0
作者：
Jieyu Wu
Yunen Lin
Xinming He
Haihong Yang
Ping He
Xinge Fu
Guangqiu Li
Xia Gu
机构：
[1] the First Affiliated Hospital of Guangzhou Medical University,Department of Pathology
[2] the First Affiliated Hospital of Guangzhou Medical University,Department of Cardiothoracic Surgery
来源：
BMC Cancer | / 16卷
关键词：
ROS1; Immunohistochemistry; Fluorescent ; hybridization; Quantitative real-time polymerase chain reaction; Non-small cell lung cancer; Tyrosine kinase inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 126 条
  • [1] Acquaviva J(1795)The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer Biochim Biophys Acta 2009 37-52
  • [2] Wong R(2015)Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma BMC Cancer 15 721-58
  • [3] Charest A(2012)Analysis of receptor tyrosine kinase ROS1-positive tumors in non-small cell lung cancer: identification of a FIG-ROS1 fusion Clin Cancer Res 18 4449-75
  • [4] Lee KH(2013)Novel targets in non-small cell lung cancer: ROS1 and RET fusions Oncologist 18 865-203
  • [5] Lee KB(2007)Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer Cell 131 1190-9
  • [6] Kim TY(2012)Identifying and targeting ROS1 gene fusions in non-small cell lung cancer Clin Cancer Res 18 4570-5
  • [7] Han SW(2013)Molecular pathways: ROS1 fusion proteins in cancer Clin Cancer Res 19 4040-71
  • [8] Oh DY(2014)Crizotinib in ROS1-rearranged non-small-cell lung cancer N Engl J Med 371 1963-3
  • [9] Im SA(2015)Validating ROS1 Rearrangements as a therapeutic target in non-small-cell lung cancer J Clin Oncol 33 1-9
  • [10] Rimkunas VM(2015)Parallel screening for ALK, MET and ROS1 alterations in non-small cell lung cancer with implications for daily routine testing Lung Cancer 87 122-7
12345678910